IRIS UniCatt

Giampietro, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.294
AS - Asia 3.611
EU - Europa 3.431
SA - Sud America 846
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 104
OC - Oceania 8
AN - Antartide 1
Totale 13.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.110
SG - Singapore 1.541
DE - Germania 1.140
CN - Cina 789
BR - Brasile 685
IT - Italia 589
VN - Vietnam 461
SE - Svezia 424
FR - Francia 276
UA - Ucraina 185
GB - Regno Unito 167
BD - Bangladesh 166
IE - Irlanda 123
IN - India 119
RU - Federazione Russa 115
FI - Finlandia 111
ID - Indonesia 108
JP - Giappone 101
CA - Canada 94
PL - Polonia 88
HK - Hong Kong 79
AR - Argentina 65
NL - Olanda 55
MX - Messico 49
IQ - Iraq 39
ES - Italia 34
TR - Turchia 32
ZA - Sudafrica 28
AT - Austria 27
EC - Ecuador 26
BE - Belgio 25
KR - Corea 20
CO - Colombia 18
PK - Pakistan 18
VE - Venezuela 18
EG - Egitto 17
SA - Arabia Saudita 17
IR - Iran 15
AE - Emirati Arabi Uniti 14
MA - Marocco 13
UZ - Uzbekistan 13
CL - Cile 12
PE - Perù 10
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
JM - Giamaica 9
KE - Kenya 9
MY - Malesia 9
PT - Portogallo 9
AL - Albania 8
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
PH - Filippine 8
PY - Paraguay 8
MD - Moldavia 7
RO - Romania 7
TN - Tunisia 7
CR - Costa Rica 6
JO - Giordania 6
LK - Sri Lanka 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
NP - Nepal 5
AU - Australia 4
BS - Bahamas 4
CH - Svizzera 4
GR - Grecia 4
HN - Honduras 4
LB - Libano 4
OM - Oman 4
RS - Serbia 4
SN - Senegal 4
AM - Armenia 3
BH - Bahrain 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
GH - Ghana 2
IL - Israele 2
KG - Kirghizistan 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SV - El Salvador 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
Totale 13.279
Salva come PNG Salva come JPEG
Città #
Singapore 849
Chandler 582
Ashburn 516
San Jose 506
New York 227
Ho Chi Minh City 167
Beijing 162
Los Angeles 160
Rome 143
Dublin 115
San Mateo 110
Hanoi 101
Lauterbourg 92
Jakarta 87
The Dalles 86
Ann Arbor 82
Milan 82
Tokyo 82
Dallas 81
Hefei 80
Moscow 76
Warsaw 76
Jacksonville 75
Munich 73
São Paulo 73
Wilmington 72
Hong Kong 70
Fairfield 68
Frankfurt am Main 65
Marseille 62
Boston 61
Tukwila 58
Nürnberg 55
St Louis 54
Santa Clara 52
Chicago 49
Houston 49
Nanjing 48
Helsinki 45
Bremen 44
Seattle 44
Buffalo 43
Princeton 41
Cattolica 40
Montreal 38
Dearborn 34
Redwood City 31
Boardman 30
Brooklyn 30
Denver 30
Kent 30
Orem 30
Shanghai 30
London 29
Woodbridge 29
Turku 26
Brussels 24
Cambridge 24
Da Nang 24
Nanchang 24
Nuremberg 23
Rio de Janeiro 23
Hangzhou 22
Lawrence 22
Atlanta 21
Mountain View 20
Zhengzhou 19
Guangzhou 17
Hyderabad 17
North Bergen 17
University Park 17
Amsterdam 16
Belo Horizonte 16
Phoenix 16
Las Vegas 15
Mumbai 15
Seoul 15
Shenyang 15
Toronto 15
Augusta 14
Council Bluffs 14
Fremont 14
Haiphong 14
Johannesburg 14
Mexico City 14
Paris 13
Poplar 13
Vienna 13
Baghdad 12
Düsseldorf 12
Norwalk 12
San Francisco 12
Stockholm 12
Tashkent 12
Bexley 11
Dhaka 11
Kunming 11
Lappeenranta 11
Leawood 11
Newark 11
Totale 6.768
Salva come PNG Salva come JPEG
Nome #
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 351
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 328
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 308
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 240
Double pituitary adenomas 239
Role of a mini-invasive approach in the diagnosis and treatment of tubo-peritoneal infertility as an altenative to IVF [Il ruolo di un approccio chirurgico mini-invasivo nella diagnosi e trattamento della sterilità tubo-peritoneale in alternativa alla FIVET] 227
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 223
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 217
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 212
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 204
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 203
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 201
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 200
Male fertility and reduction in semen parameters: A single tertiary-care center experience 196
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 193
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 192
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 180
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 175
Isolated growth hormone deficiency: clinical entity? 169
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 163
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 161
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 159
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 155
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 153
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 153
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 152
The Changing Clinical Spectrum of Hypophysitis 152
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 151
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 149
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 148
Fertility and hypopituitarism 146
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 146
GH receptor isoforms and skeletal fragility in acromegaly 142
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 140
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 136
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 134
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 134
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 131
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 130
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 129
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 129
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 129
Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism 128
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 125
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 124
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 123
Empty sella syndrome: Multiple endocrine disorders. 120
Hypothalamitis and pituitary atrophy 120
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 119
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 119
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 118
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 115
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 115
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 113
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 112
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry 112
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 111
Understanding the effect of acromegaly on the human skeleton. 111
Acromegaly in the elderly patients 111
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 110
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 109
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 108
Vertebral fractures in patients with acromegaly: a 3-year prospective study 108
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 108
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 107
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 105
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 105
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 103
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 102
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 101
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 99
Empty sella syndrome: an update 98
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 97
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study 97
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 96
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 95
Acromegaly can be cured by first-line pasireotide treatment? 93
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 91
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 88
De-escalation treatment with pasireotide for acromegaly: a long-term experience 87
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 87
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients 86
Solitary Metastatic Melanoma of the Pituitary Gland: Report of Two Cases and Literature Review 84
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study 83
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 82
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 82
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience 81
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 81
A Toluene-induced Infundibulo-neuro-hypophysitis: Presentation of a New Cause of Hypophysitis Secondary to Toxic Exposure and Review on Toluene Inhalation Endocrine Effects 79
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 79
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 75
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences 74
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort 73
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 69
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 68
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 65
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 64
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review 63
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 63
Vitamin D in pituitary driven osteopathies 60
Totale 13.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022587 0 33 7 47 74 27 10 112 28 26 85 138
2022/20231.516 173 207 123 252 80 211 89 127 157 13 53 31
2023/2024717 32 160 17 32 31 142 35 8 28 34 93 105
2024/20251.843 30 40 124 75 101 74 37 67 273 188 395 439
2025/20266.041 736 221 421 769 846 287 884 313 297 432 590 245
2026/2027497 411 86 0 0 0 0 0 0 0 0 0 0
Totale 13.474